The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030, claims Roots Analysis
26 oct. 2021 09h15 HE
|
Roots Analysis
London, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings. Success of approved...
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
09 nov. 2020 08h00 HE
|
Checkpoint Therapeutics, Inc
44.0% objective response rate and 10.3-month median progression-free survival observed in non-small cell lung cancer (NSCLC) cohortPhase 3 registration-enabling trial planned in first-line metastatic...
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
05 sept. 2019 08h30 HE
|
Genprex, Inc.
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights
26 juil. 2019 11h03 HE
|
Fortune Business Insights
Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small...
Non-Small Cell Lung Cancer Market To Reach USD 10.53 Billion By 2026 | Reports And Data
05 juin 2019 11h51 HE
|
Reports And Data
Increase in the understanding of diseases and research into the development of new drugs for non-small cell lung cancer is fueling the market growth. Market Size – USD 6.45 Billion in 2018, Market...
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
31 mai 2019 08h30 HE
|
Genprex, Inc.
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully...
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
09 mai 2019 08h30 HE
|
Genprex, Inc.
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
08 mai 2019 08h30 HE
|
Genprex, Inc.
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
12 avr. 2019 09h00 HE
|
Genprex, Inc.
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
11 avr. 2019 08h30 HE
|
Genprex, Inc.
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...